Govt defends delay in giving AIDS drugs
Government believes that it has acted responsibly by introducing the anti-AIDS drug, nevirapine, in a “controlled process” at 18 pilot sites countrywide.
This is according to affidavits filed in the Pretoria High Court by the Minister of Health, Dr Manto Tshabalala-Msimang, and eight provincial health MECs (excluding the Western Cape) in response to a court challenge by the Treatment Action Campaign (TAC).
TAC has initiated court action against the minister and her MECs in a bid to ensure that doctors in public health are allowed to prescribe nevirapine to HIV positive pregnant women and that, within 18 months, the drug is available at all public health facilities nationwide.
The Western Cape has been excluded from the court action as it is committed to providing nevirapine at all its health facilities.
Nevirapine can reduce the transmission rate of HIV from infected mothers to their babies in vitro and during labour by up to 50%. An estimated 70 000 babies are born with HIV every year in South Africa.
However, in the affidavits – which run to hundreds of pages – the respondents assert the “reasonable and rational nature” of introducing nevirapine at the 18 sites.
They also argue that TAC is asking the court to make a “policy choice”, yet it is not the court’s role to do so.
TAC has until Tuesday to respond to the government’s affidavits, and was busy formulating its response at the time of going to press.
TAC leadership recently wrote to Tshabalala Msimang, appealing to her to “abandon your opposition to the court case and to once again give people hope in the government”.
The case has been provisionally set down for 26 and 27 November, and TAC is planning massive protests to coincide with the start of it.
– Health-e News Service.
Author
Kerry Cullinan is the Managing Editor at Health-e News Service. Follow her on Twitter @kerrycullinan11
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Govt defends delay in giving AIDS drugs
by Kerry Cullinan, Health-e News
October 31, 2001